LINCOLN NATIONAL CORP - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q1 2021$76,000
+111.1%
16,6470.0%0.00%
+100.0%
Q4 2020$36,000
-7.7%
16,6470.0%0.00%0.0%
Q3 2020$39,000
+18.2%
16,6470.0%0.00%0.0%
Q2 2020$33,00016,6470.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q4 2020
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders